EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)
Conditions: Acute Decompensated Heart Failure Interventions: Device: Reprieve Decongestion Management System; Drug: Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide) Sponsors: Reprieve Cardiovascular, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Effect of Urine Acid-base Disequilibrium on the Pharmacokinetics of Captopril
Conditions: Hypertension Interventions: Drug: Captopril 12.5 Mg; Drug: Sodium bicarbonate 4 G; Drug: Torsemide 20 MG Sponsors: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Conditions: Heart Failure, Congestive Interventions: Drug: Furosemide; Drug: Torsemide; Drug: Bumetanide; Drug: sacubitril/valsartan; Drug: Hydralazine; Drug: Isosorbide Dinitrate Sponsors: Heart Center Research, LLC; Boston Scientific Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
Conditions: Heart Failure; Overactive Bladder; Incontinence Interventions: Drug: Extended release torsemide; Drug: Immediate release torsemide; Drug: Extended release torsemide placebo; Drug: Immediate release torsemide placebo Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Immediate Release Versus Extended Release Torsemide After Salty Meal
Conditions: Heart Failure Interventions: Drug: immediate release torsemide 20mg tablet Sponsors: University of Florida; Sarfez Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Comparison of Diuretics Shows No Difference in Heart Failure Survival
NIH-funded clinical trial underscores need for better treatments for deadly condition.
January 17, 2023 -- Two drugs widely used to treat adults with heart failure– furosemide and torsemide– showed no difference in their ability... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 17, 2023 Category: Pharmaceuticals Source Type: clinical trials
Diuretics and Volume Overload in Early CKD
Conditions: Chronic Kidney Disease; Hypertension Intervention: Drug: Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide) Sponsor: VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2021 Category: Research Source Type: clinical trials
Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure
Condition: Heart Failure Interventions: Drug: Furosemide; Drug: Torsemide Sponsor: Yale University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2021 Category: Research Source Type: clinical trials
